LINC00460 and head and neck squamous cell carcinoma: Qiu et al. (2019) found that knockdown of RHPN1-AS1 inhibited cell migration, invasion and proliferation of HNSCC, indicating that RHPN1-AS1, acting as an oncogene, may be a potential diagnostic and therapeutic target in HNSCC. Jiang et al. (2019) suggested that LINC00460 facilitated PRDX1 entry into the nucleus and promoted EMT in HNSCC cells.